CMRX $2.10 in cash and no debt / enough to sustain through 2026
smart investors / Insiders are buying as well / year end tax loss harvesting is almost done and I believe biotechs will run fast in jan / feb
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。